about
Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 casesProfile of palbociclib in the treatment of metastatic breast cancerThe fate of chemoresistance in triple negative breast cancer (TNBC)Targeted Therapies in Triple-Negative Breast CancerThe role of taxanes in triple-negative breast cancer: literature reviewTargeting triple-negative breast cancer: optimising therapeutic outcomesCurrent treatment of early breast cancer: adjuvant and neoadjuvant therapyTriple-negative breast cancer: is there a treatment on the horizon?Therapeutic targets of triple-negative breast cancer: a reviewImaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium CompoundExpression and function of MutT homolog 1 in distinct subtypes of breast cancer.Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer.Association between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis.The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.Hereditary breast cancer: clinical, pathological and molecular characteristics.pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.Repositioning of Verrucosidin, a purported inhibitor of chaperone protein GRP78, as an inhibitor of mitochondrial electron transport chain complex I.Triple negative breast cancers have a reduced expression of DNA repair genesPharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cellsβ3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells.A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana.Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women.Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.Expression of MAS1 in breast cancer.Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.The origin of breast tumor heterogeneity.Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cellsPositive expression of miR-361-5p indicates better prognosis for breast cancer patients.New criteria to predict tumor recurrence in invasive ductal carcinoma of the breastSubstituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer CellsTheranostic barcoded nanoparticles for personalized cancer medicine5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cellsPolymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk.Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells
P2860
Q21999477-AF434111-F00C-40A5-B09E-CA15196E964EQ26747737-BFCCCE7C-DF28-457C-B289-117A81DBD33CQ26775232-8C487B6E-62EA-4291-B035-4BD67E3B6E35Q26777736-87D7089B-2253-40E1-B824-C6097F6554CCQ26798356-172B6A94-762D-4F2F-9BDF-79F724CF4F27Q26850892-258B726C-2FAC-478E-B436-A0687B3D8877Q27011658-7FB06D53-5D2F-4C81-9527-A124411617C5Q28077243-EF6F8CCD-92B5-4DF8-ABFE-EA4B2AE01528Q28081591-D69A9072-73CC-43FC-9B56-A154B87CF5C5Q28550925-F1992669-94DB-4491-A27A-5241A6EE4BC1Q33598769-64C55DF6-AFC1-4463-A0E0-7771D745FD90Q33683673-AAE8B6AE-6299-4064-8378-A5EC53E3A777Q33857861-EC5CCBED-BD19-4C93-9197-532939DE8587Q33903662-21682FDE-67DD-48A9-9088-4D29C6750EB3Q34152071-F19E2D2C-E5EB-4883-B323-BC65FA4915B4Q34425230-E0EDAE27-CD85-486F-B532-71F306D58632Q34630304-95B8C75E-2533-4A58-B563-B98923B42487Q34766688-21B22483-775E-482C-8658-57D6F4B5BAFAQ34794035-62AC3FAF-42BF-4C4E-BA27-6F49F8B4829CQ34956648-2B42B05E-29F9-4E1F-9EA0-E7E608DF0817Q35551725-2F0106EB-449B-4F2F-868A-79A227A0C0C4Q35687586-FA64455C-E3C0-4CE1-A82C-5D2CD6AB37E5Q35980877-7B92EE34-67CC-4D2F-AC7C-08140C9FC61DQ35998714-CC161E16-2A8A-4304-8289-32F8B9EFBE23Q36092905-F91A9564-EDF5-42AC-A3D0-F2DCF51BB5FBQ36213528-6A9DF029-6F9D-49B0-B182-00A04623E1C9Q36244761-56899D9E-DDB7-4592-8614-4AF46ABFDDD3Q36328710-6281CB12-B09A-4C9E-B314-85B278F4389DQ36365067-1EC793CB-CAB4-4B74-BC64-AFB5E603564CQ36525461-CC26A53B-EC78-48B6-B1F0-0DBC0CFC5E6FQ36545926-4ACBD460-B579-42F4-8F31-A0D45983C447Q36640972-5D34A980-EFD0-4A13-A1A5-EFF97F5CA858Q37109827-D06DECDB-79C9-476D-B456-1F67303A967CQ37121435-52773A41-DCCA-49ED-8FCD-763A4295B73FQ37311070-5D281FC4-743B-4FF7-9297-F206B781F655Q37407219-A5C37842-21F4-4268-92F3-4C5B53A92B0EQ37414318-7EBE5C10-2C1E-4AEB-8F87-EBD4D7C423BCQ37438076-755174ED-E4F7-4658-B95D-2AFBC674D774Q37471156-632CBB45-B10D-42C0-BC1A-C280DA0E18E1Q37511632-BBF75D62-5644-46D5-88D5-AD655E7F50A2
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Characteristics of triple-negative breast cancer
@ast
Characteristics of triple-negative breast cancer
@en
Characteristics of triple-negative breast cancer
@nl
type
label
Characteristics of triple-negative breast cancer
@ast
Characteristics of triple-negative breast cancer
@en
Characteristics of triple-negative breast cancer
@nl
prefLabel
Characteristics of triple-negative breast cancer
@ast
Characteristics of triple-negative breast cancer
@en
Characteristics of triple-negative breast cancer
@nl
P2093
P2860
P921
P1476
Characteristics of triple-negative breast cancer
@en
P2093
Joep P J de Hoon
Manon van Engeland
Tim C de Ruijter
Vivianne C Tjan-Heijnen
P2860
P2888
P304
P356
10.1007/S00432-010-0957-X
P577
2010-11-11T00:00:00Z
2011-02-01T00:00:00Z